buformin has been researched along with Aging in 2 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anisimov, VN | 1 |
Semenchenko, AV | 1 |
Yashin, AI | 1 |
Mori, K | 1 |
Nakamura, J | 1 |
Koh, N | 1 |
Sakakibara, F | 1 |
Hamada, Y | 1 |
Hara, T | 1 |
Komori, T | 1 |
Nakashima, E | 1 |
Naruse, K | 1 |
Takeuchi, N | 1 |
Hotta, N | 1 |
2 other studies available for buformin and Aging
Article | Year |
---|---|
Insulin and longevity: antidiabetic biguanides as geroprotectors.
Topics: Aging; Animals; Buformin; Female; Humans; Hypoglycemic Agents; Insulin; Longevity; Mice; Neoplasms; | 2003 |
Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.
Topics: Aging; Alanine; Animals; Body Weight; Buformin; Cells, Cultured; Diabetes Mellitus, Experimental; Di | 1997 |